Last Updated：2025/11/28
In a clinical trial, farletuzumab showed promising activity against ovarian cancer in a subset of patients.
See correct answer
In a clinical trial, farletuzumab showed promising activity against ovarian cancer in a subset of patients.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
